Plants and their active compounds: natural molecules to target angiogenesis

[1]  C. Supuran,et al.  Challenging Organic Syntheses and Pharmacological Applications of Natural Products and their Derivatives - Part II. , 2016, Current pharmaceutical design.

[2]  A. Azmi,et al.  Broad targeting of angiogenesis for cancer prevention and therapy , 2015, Seminars in cancer biology.

[3]  Yuehua Wu,et al.  Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13. , 2015, Journal of molecular and cellular cardiology.

[4]  S. Basu,et al.  The natural compound chebulagic acid inhibits vascular endothelial growth factor A mediated regulation of endothelial cell functions , 2015, Scientific Reports.

[5]  C. Supuran,et al.  Editorial: Challenging Organic Syntheses and Pharmacological Applications of Natural Products and their Derivatives. , 2015, Current pharmaceutical design.

[6]  J. F. Arevalo,et al.  Diabetic macular edema: changing treatment paradigms , 2014, Current opinion in ophthalmology.

[7]  F. Gueyffier,et al.  Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis. , 2014, JAMA ophthalmology.

[8]  You-Jin Choi,et al.  Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages. , 2014, International immunopharmacology.

[9]  Sharon D. Solomon,et al.  Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. , 2014, The Cochrane database of systematic reviews.

[10]  D. Ribatti,et al.  Insights in Hodgkin Lymphoma angiogenesis. , 2014, Leukemia research.

[11]  M. Tonelli,et al.  Systematic Review of the Risk of Adverse Outcomes Associated with Vascular Endothelial Growth Factor Inhibitors for the Treatment of Cancer , 2014, PloS one.

[12]  Juan Zhou,et al.  Molecular Analysis of Curcumin-induced Polarization of Murine RAW264.7 Macrophages , 2014, Journal of cardiovascular pharmacology.

[13]  Rim S Ishak,et al.  Cutaneous manifestations of anti-angiogenic therapy in oncology: Review with focus on VEGF inhibitors. , 2014, Critical reviews in oncology/hematology.

[14]  Yitao Wang,et al.  Erratum to: Enhancing the Antitumor Activity of Berberine Hydrochloride by Solid Lipid Nanoparticle Encapsulation , 2014, AAPS PharmSciTech.

[15]  H. Gerding,et al.  Intravitreale Anti-VEGF-Behandlung choroidaler Neovaskularisationen (CNV) bei pathologischer Myopie (PM): ein Review , 2014, Klin Monatsbl Augenheilkd.

[16]  A. Orekhov,et al.  Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis , 2014, Front. Physiol..

[17]  Leonard K. Seibold,et al.  The link between intravitreal antivascular endothelial growth factor injections and glaucoma , 2014, Current opinion in ophthalmology.

[18]  Wim E Hennink,et al.  Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. , 2014, Biomaterials.

[19]  A. Chetta,et al.  Therapeutic perspectives in vascular remodeling in asthma and chronic obstructive pulmonary disease. , 2014, Chemical immunology and allergy.

[20]  F. Levi-Schaffer,et al.  Roles of eosinophils in the modulation of angiogenesis. , 2014, Chemical immunology and allergy.

[21]  Yitao Wang,et al.  Enhancing the Antitumor Activity of Berberine Hydrochloride by Solid Lipid Nanoparticle Encapsulation , 2014, AAPS PharmSciTech.

[22]  G. Casalino,et al.  Pharmacological Approach to Diabetic Macular Edema , 2013, Ophthalmic Research.

[23]  A. Khuda-Bukhsh,et al.  Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends. , 2013, European journal of pharmacology.

[24]  B. Aggarwal,et al.  Curcumin: an orally bioavailable blocker of TNF and other pro‐inflammatory biomarkers , 2013, British journal of pharmacology.

[25]  P. K. Kanaujia,et al.  Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2–mediated angiogenesis , 2013, Molecular Cancer.

[26]  Tingmei Chen,et al.  Hydrazinocurcumin Encapsuled Nanoparticles “Re-Educate” Tumor-Associated Macrophages and Exhibit Anti-Tumor Effects on Breast Cancer Following STAT3 Suppression , 2013, PloS one.

[27]  S. Saraswati,et al.  Brucine, an indole alkaloid from Strychnos nux-vomica attenuates VEGF-induced angiogenesis via inhibiting VEGFR2 signaling pathway in vitro and in vivo. , 2013, Cancer letters.

[28]  Sang Kook Lee,et al.  6″-Debromohamacanthin A, a Bis (Indole) Alkaloid, Inhibits Angiogenesis by Targeting the VEGFR2-Mediated PI3K/AKT/mTOR Signaling Pathways , 2013, Marine drugs.

[29]  Y. Jeon,et al.  Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization , 2013, BMC Cancer.

[30]  K. Sak.  Chemotherapy and Dietary Phytochemical Agents , 2012, Chemotherapy research and practice.

[31]  S. Chatterjee,et al.  Use of natural molecules as anti-angiogenic inhibitors for vascular endothelial growth factor receptor , 2012, Bioinformation.

[32]  B. Al-Husein,et al.  Antiangiogenic Therapy for Cancer: An Update , 2012, Pharmacotherapy.

[33]  K. Plate,et al.  Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited , 2012, Acta Neuropathologica.

[34]  Zhongfa Liu,et al.  Triphala and Its Active Constituent Chebulinic Acid Are Natural Inhibitors of Vascular Endothelial Growth Factor-A Mediated Angiogenesis , 2012, PloS one.

[35]  Shuai Lu,et al.  Norisoboldine, an alkaloid compound isolated from Radix Linderae, inhibits synovial angiogenesis in adjuvant-induced arthritis rats by moderating Notch1 pathway-related endothelial tip cell phenotype , 2012, Experimental biology and medicine.

[36]  Haitao Luo,et al.  Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability , 2012, International journal of nanomedicine.

[37]  M. Recio,et al.  Anti-inflammatory agents from plants: progress and potential. , 2012, Current medicinal chemistry.

[38]  F. Rodeghiero,et al.  Side effects of anti-angiogenic drugs. , 2012, Thrombosis research.

[39]  D. Cheresh,et al.  Tumor angiogenesis: molecular pathways and therapeutic targets , 2011, Nature Medicine.

[40]  Napoleone Ferrara,et al.  Developmental and pathological angiogenesis. , 2011, Annual review of cell and developmental biology.

[41]  Xia Zhao,et al.  Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. , 2011, Nanoscale.

[42]  R. Samant,et al.  Recent Advances in Anti-Angiogenic Therapy of Cancer , 2011, Oncotarget.

[43]  Lawrence H. Schwartz,et al.  Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  Yi-Zhong Cai,et al.  Natural Phenolic Compounds From Medicinal Herbs and Dietary Plants: Potential Use for Cancer Prevention , 2009, Nutrition and cancer.

[45]  M. Röcken,et al.  Angiogenesis drives psoriasis pathogenesis , 2009, International journal of experimental pathology.

[46]  S. Mousa,et al.  Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. , 2009, Cancer research.

[47]  L. Dwyer-Nield,et al.  Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor-κB and Signal Transducers and Activators of Transcription 3 , 2009, Cancer Prevention Research.

[48]  Shiuan Chen,et al.  Grape Seed Extract Inhibits Angiogenesis via Suppression of the Vascular Endothelial Growth Factor Receptor Signaling Pathway , 2008, Cancer Prevention Research.

[49]  P. Albertsson,et al.  Dose effects of continuous vinblastine chemotherapy on mammalian angiogenesis mediated by VEGF-A , 2008, Acta oncologica.

[50]  S. Tewtrakul,et al.  Anti-allergic activity of some selected plants in the Zingiberaceae family. , 2007, Journal of ethnopharmacology.

[51]  T. He,et al.  Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells , 2007, Cancer Chemotherapy and Pharmacology.

[52]  S. Sagar,et al.  Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer—Part 2 , 2006, Current oncology.

[53]  G. Hospers,et al.  A review on pro- and anti-angiogenic factors as targets of clinical intervention. , 2006, Pharmacological research.

[54]  S. Sagar,et al.  Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer—Part 1 , 2006, Current oncology.

[55]  H. Niimi,et al.  Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. , 2006, Clinical hemorheology and microcirculation.

[56]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[57]  P. Giannakakou,et al.  Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function. , 2005, Cancer research.

[58]  R. Kalluri,et al.  Endogenous inhibitors of angiogenesis. , 2005, Cancer research.

[59]  E. Woltering,et al.  Colchicine and 2-methoxyestradiol Inhibit Human Angiogenesis. , 2005, The Journal of surgical research.

[60]  K. Gupta,et al.  Angiogenesis: a curse or cure? , 2005, Postgraduate Medical Journal.

[61]  Bart Landuyt,et al.  Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.

[62]  Xianglin Shi,et al.  trans-3,4,5′-Trihydroxystibene Inhibits Hypoxia-Inducible Factor 1α and Vascular Endothelial Growth Factor Expression in Human Ovarian Cancer Cells , 2004, Clinical Cancer Research.

[63]  Liliana Jiménez,et al.  Polyphenols: food sources and bioavailability. , 2004, The American journal of clinical nutrition.

[64]  G. Koh,et al.  Suppression of angiogenesis by the plant alkaloid, sanguinarine. , 2004, Biochemical and biophysical research communications.

[65]  R. Agarwal,et al.  Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[66]  R. Liu,et al.  Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. , 2003, The American journal of clinical nutrition.

[67]  P. Carmeliet.  Angiogenesis in health and disease , 2003, Nature Medicine.

[68]  A. Albini,et al.  Neutrophil Restraint by Green Tea: Inhibition of Inflammation, Associated Angiogenesis, and Pulmonary Fibrosis1 , 2003, The Journal of Immunology.

[69]  Masumi Suzui,et al.  Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. , 2002, Journal of experimental therapeutics & oncology.

[70]  L. Ellis,et al.  Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. , 2002, The Journal of nutrition.

[71]  E. Paleolog.  Angiogenesis in rheumatoid arthritis , 2002, Arthritis research.

[72]  Erwin G. Van Meir,et al.  Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. , 2002, Cancer research.

[73]  Yihai Cao,et al.  Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  L. Ellis,et al.  EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells , 2001, British Journal of Cancer.

[75]  R. Agarwal,et al.  Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells. , 2000, Biochemical and biophysical research communications.

[76]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[77]  G. Semenza,et al.  Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. , 2000, Cancer research.

[78]  M. M. Cowan.  Plant Products as Antimicrobial Agents , 1999, Clinical Microbiology Reviews.

[79]  Y. Sadzuka,et al.  Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma. , 1998, Cancer letters.

[80]  J. Arbiser,et al.  Curcumin Is an In Vivo Inhibitor of Angiogenesis , 1998, Molecular medicine.

[81]  H. Adlercreutz,et al.  Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. , 1997, Cancer research.

[82]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[83]  M. S. Lakshmi,et al.  Angiogenesis in cancer , 1997 .

[84]  J. Folkman,et al.  Fighting cancer by attacking its blood supply. , 1996, Scientific American.

[85]  Y. Yoo,et al.  Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. , 1995, Biological & pharmaceutical bulletin.

[86]  N. Morisaki,et al.  Mechanism of angiogenic effects of saponin from Ginseng Radix rubra in human umbilical vein endothelial cells , 1995, British journal of pharmacology.

[87]  A. Passaniti,et al.  The α-Glucosidase I Inhibitor Castanospermine Alters Endothelial Cell Glycosylation, Prevents Angiogenesis, and Inhibits Tumor Growth , 1995 .

[88]  H. Adlercreutz,et al.  Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. , 1995, The Journal of nutrition.

[89]  A. Passaniti,et al.  The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. , 1995, Cancer research.

[90]  E. de Juan,et al.  Phosphotyrosine inhibition and control of vascular endothelial cell proliferation by genistein. , 1994, Biochemical pharmacology.

[91]  Katsuaki Sato,et al.  Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. , 1994, Biological & pharmaceutical bulletin.

[92]  L. Norton,et al.  Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity , 1994, International journal of clinical & laboratory research.

[93]  A. Logan,et al.  Angiogenesis , 1993, The Lancet.

[94]  H. Adlercreutz,et al.  Genistein, a dietary-derived inhibitor of in vitro angiogenesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[95]  J. Folkman,et al.  Angiogenic factors. , 1987, Science.